169 related articles for article (PubMed ID: 21755566)
1. Hypomethylation of the 14-3-3σ promoter leads to increased expression in non-small cell lung cancer.
Radhakrishnan VM; Jensen TJ; Cui H; Futscher BW; Martinez JD
Genes Chromosomes Cancer; 2011 Oct; 50(10):830-6. PubMed ID: 21755566
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor gene 14-3-3sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in non-small cell lung cancers as identified by proteomic profiling.
Liu Y; Chen Q; Zhang JT
J Proteome Res; 2004; 3(4):728-35. PubMed ID: 15359725
[TBL] [Abstract][Full Text] [Related]
3. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group.
Ramirez JL; Rosell R; Taron M; Sanchez-Ronco M; Alberola V; de Las Peñas R; Sanchez JM; Moran T; Camps C; Massuti B; Sanchez JJ; Salazar F; Catot S;
J Clin Oncol; 2005 Dec; 23(36):9105-12. PubMed ID: 16361617
[TBL] [Abstract][Full Text] [Related]
5. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
Shiba-Ishii A; Noguchi M
Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
[TBL] [Abstract][Full Text] [Related]
6. Aberrant overexpression of an epithelial marker, 14-3-3sigma, in a subset of hematological malignancies.
Motokura T; Nakamura Y; Sato H
BMC Cancer; 2007 Nov; 7():217. PubMed ID: 18036248
[TBL] [Abstract][Full Text] [Related]
7. Regulation of 14-3-3sigma expression in human thyroid carcinoma is epigenetically regulated by aberrant cytosine methylation.
Lal G; Padmanabha L; Provenzano M; Fitzgerald M; Weydert J; Domann FE
Cancer Lett; 2008 Aug; 267(1):165-74. PubMed ID: 18440129
[TBL] [Abstract][Full Text] [Related]
8. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
9. Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.
Osada H; Tatematsu Y; Yatabe Y; Nakagawa T; Konishi H; Harano T; Tezel E; Takada M; Takahashi T
Oncogene; 2002 Apr; 21(15):2418-24. PubMed ID: 11948426
[TBL] [Abstract][Full Text] [Related]
10. Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells.
Gagnon J; Shaker S; Primeau M; Hurtubise A; Momparler RL
Anticancer Drugs; 2003 Mar; 14(3):193-202. PubMed ID: 12634613
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation.
Mhawech P; Benz A; Cerato C; Greloz V; Assaly M; Desmond JC; Koeffler HP; Lodygin D; Hermeking H; Herrmann F; Schwaller J
Mod Pathol; 2005 Mar; 18(3):340-8. PubMed ID: 15257317
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of the cell type-specific gene 14-3-3sigma.
Oshiro MM; Futscher BW; Lisberg A; Wozniak RJ; Klimecki WT; Domann FE; Cress AE
Neoplasia; 2005 Sep; 7(9):799-808. PubMed ID: 16229802
[TBL] [Abstract][Full Text] [Related]
13. Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3sigma.
Han B; Xie H; Chen Q; Zhang JT
Mol Cancer Ther; 2006 Apr; 5(4):903-12. PubMed ID: 16648560
[TBL] [Abstract][Full Text] [Related]
14. Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome.
Holm R; Ali T; Svendsrud DH; Nesland JM; Kristensen GB; Lyng H
Oncol Rep; 2009 Jul; 22(1):11-5. PubMed ID: 19513498
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence.
Schultz J; Ibrahim SM; Vera J; Kunz M
Mol Cancer; 2009 Jul; 8():53. PubMed ID: 19642975
[TBL] [Abstract][Full Text] [Related]
16. Interaction of 14-3-3σ with KCMF1 suppresses the proliferation and colony formation of human colon cancer stem cells.
Zou J; Mi L; Yu XF; Dong J
World J Gastroenterol; 2013 Jun; 19(24):3770-80. PubMed ID: 23840115
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of 14-3-3σ is predictive of poor prognosis for patients with human uterine papillary serous carcinoma.
Suzuki F; Nagase S; Suzuki K; Oba E; Hiroki E; Matsuda Y; Akahira J; Nishigori H; Sugiyama T; Otsuki T; Yoshinaga K; Takano T; Niikura H; Ito K; Sasano H; Yaegashi N
Tohoku J Exp Med; 2013 Nov; 231(3):193-9. PubMed ID: 24201220
[TBL] [Abstract][Full Text] [Related]
18. Methylation markers of early-stage non-small cell lung cancer.
Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
PLoS One; 2012; 7(6):e39813. PubMed ID: 22768131
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.
Pastuszak-Lewandoska D; Kordiak J; Migdalska-Sęk M; Czarnecka KH; Antczak A; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska D; Brzeziańska-Lasota E
Respir Res; 2015 Jun; 16(1):76. PubMed ID: 26112163
[TBL] [Abstract][Full Text] [Related]
20. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
Yang H; Zhao R; Lee MH
Mol Cancer Ther; 2006 Feb; 5(2):253-60. PubMed ID: 16505098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
